Acquisition of Manufacturing and Marketing Approval for SARS-CoV-2 Antigen Rapid Test and Release on 14th February

TOKYO, JAPAN - Medical & Biological Laboratories Co., Ltd. (President: Kimimasa Yamada), a JSR Life Sciences company, successfully acquired manufacturing and marketing approval for a rapid antigen test for SARS-CoV-2, “GLINE-2019-nCoV Ag kit” (Product code: YH-G86256). The kit is scheduled to be released on February 14th in Japan.

This kit enables detection of SARS-CoV-2 nucleocapsid proteins in nasopharyngeal and nasal swabs by the immunochromatography method. With a simple operation, the presence or absence of the SARS-CoV-2 antigen can be determined in 15 minutes.

Contact details

Receive exclusive news

Are you a journalist or do you work for a publication?
Sign up and request access to exclusive news.

Request access

Receive JSR Life Sciences news on your RSS reader.

Or subscribe through Atom URL manually